Novo Nordisk A/S (NYSE:NVO – Get Free Report) declared a semi-annual dividend on Tuesday, August 6th, Wall Street Journal reports. Investors of record on Friday, August 16th will be given a dividend of 0.5126 per share on Monday, August 26th. This represents a dividend yield of 0.7%. The ex-dividend date is Friday, August 16th.
Novo Nordisk A/S has increased its dividend by an average of 16.5% annually over the last three years. Novo Nordisk A/S has a dividend payout ratio of 24.3% meaning its dividend is sufficiently covered by earnings. Research analysts expect Novo Nordisk A/S to earn $4.35 per share next year, which means the company should continue to be able to cover its $1.03 annual dividend with an expected future payout ratio of 23.7%.
Novo Nordisk A/S Stock Up 0.4 %
Novo Nordisk A/S stock traded up $0.49 during mid-day trading on Wednesday, hitting $134.06. The company’s stock had a trading volume of 1,257,206 shares, compared to its average volume of 4,518,941. Novo Nordisk A/S has a 52-week low of $86.96 and a 52-week high of $148.15. The firm’s 50 day moving average is $137.29 and its 200 day moving average is $130.46. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.70 and a quick ratio of 0.50. The company has a market cap of $601.60 billion, a PE ratio of 46.04, a price-to-earnings-growth ratio of 1.33 and a beta of 0.41.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on NVO
About Novo Nordisk A/S
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Featured Articles
- Five stocks we like better than Novo Nordisk A/S
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Brinker International’s Price Dip is an Appetizing Entry Point
- What are earnings reports?
- 3 Stocks That Could Beat the September Blues
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.